A negative trial on the effect of spirulina in COVID-19 patients or a positive trial for the scientific community?
The American Journal of Clinical Nutrition · 2024
DOI: 10.1016/j.ajcnut.2024.06.017 ↗Kurz gefasst
Editorial in der Zeitschrift The American Journal of Clinical Nutrition, 2024. Verfasst von Philipp Schuetz. Beteiligte Einrichtung: Medical University Department, Division of General Internal and Emergency Medicine, Kantonsspital Aarau, Aarau, Switzerland; Medical Faculty of the U…. Hauptthemen laut MEDLINE: COVID-19, Spirulina, SARS-CoV-2. Die Arbeit nennt 15 Literaturangaben. Gefördert von: Forschungsrat des Kantonsspitals Aarau, Bill and Melinda Gates Foundation, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Medical University Department, Division of General Internal and Emergency Medicine, Kantonsspital Aarau, Aarau, Switzerland; Medical Faculty of the University of Basel, Basel, Switzerland. Electronic address: philipp.sc…
Förderung
- Forschungsrat des Kantonsspitals Aarau
- Bill and Melinda Gates Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Zitieren
APA
Schuetz, P. (2024). A negative trial on the effect of spirulina in COVID-19 patients or a positive trial for the scientific community?. The American Journal of Clinical Nutrition. https://doi.org/10.1016/j.ajcnut.2024.06.017
Vancouver
Schuetz P. A negative trial on the effect of spirulina in COVID-19 patients or a positive trial for the scientific community?. The American Journal of Clinical Nutrition. 2024. doi:10.1016/j.ajcnut.2024.06.017
BibTeX
@article{Schuetz2024,
author = {Schuetz, Philipp},
title = {A negative trial on the effect of spirulina in COVID-19 patients or a positive trial for the scientific community?},
journal = {The American Journal of Clinical Nutrition},
year = {2024},
doi = {10.1016/j.ajcnut.2024.06.017}
}
EUVIMED